Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi - The Lancet Haematology
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE SC Regimen • Acute Myeloid Leukaemia – Cytarabine SC Indication •
Efficacy and safety of different doses of cytarabine in consolidation therapy for adult acute myeloid leukemia patients: a network meta-analysis | Scientific Reports
1182-Low dose cytarabine | eviQ
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet
SciELO - Brasil - Possible benefit of consolidation therapy with high-dose cytarabine on overall survival of adults with non-promyelocytic acute myeloid leukemia Possible benefit of consolidation therapy with high-dose cytarabine on overall
BCCA Protocol Summary for Therapy of Acute Myeloid Leukemia Using Low Dose Cytarabine
4088-Acute myeloid leukaemia STIMULus (low dose cytarabine and tioguanine) overview | eviQ
Practical Dosing Considerations for Venetoclax
Acute myeloid leukemia—Major progress over four decades and glimpses into the future - Kantarjian - 2016 - American Journal of Hematology - Wiley Online Library
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy | Journal of Hematology & Oncology | Full Text
Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low -dose cytarabine and placebo in older adults with untreated acute myeloid leukemia | Haematologica
Flow chart of protocol treatment | Download Scientific Diagram
Prevention and Treatment of Cytarabine-Induced Keratoconjunctivitis
Clinical Trial Results with Novel Agents and Regimens for the Treatment of Newly Diagnosed or Relapsed/Refractory AML/MDS, Including in the Elderly | Research To Practice
A phase I/II study of the combination of quizartinib with azacitidine or low -dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome | Haematologica
Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided
Leukemia Insights Winter 2010
Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trial - The Lancet Haematology
HIVH AML-88 Protocol. | Download Table
Novel immunomodulatory properties of low dose cytarabine entrapped in a mannosylated cationic liposome - ScienceDirect
Cancers | Free Full-Text | New Therapeutic Strategies for Adult Acute Myeloid Leukemia
Uproleselan Added to Cladribine Plus Low-Dose Cytarabine (LDAC) In Patients with Treated Secondary Acute Myeloid Leukemia (TS-AML)
Protocol Page
Prevention and Treatment of Cytarabine-Induced Keratoconjunctivitis
